Clinical Trial Update: Bortezomib-Dexamethasone-Doxorubicin-Study [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of bortezomib, dexamethasone, and doxorubicin in patients with multiple myeloma and renal insufficiency has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Renal Insufficiency

Drugs mentioned

• Adriamycin (doxorubicin) (doxorubicin)
• DEXAMETHASONE (Dexamethasone)
• Velcade (bortezomib) (bortezomib)

Snippet

Sponsor: Austrian Forum Against Cancer | Conditions: Multiple Myeloma, Renal Insuficiency | Phase 2 | Status: COMPLETED